Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica

REFERENCES

1. 1.↵
   2. Wingerchuk DM,
   3. Lennon VA,
   4. Pittock SJ, et al

   . Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485–89 doi:10.1212/01.wnl.0000216139.44259.74 pmid:16717206

   CrossRefPubMed
2. 2.↵
   2. Wingerchuk DM,
   3. Lennon VA,
   4. Lucchinetti CF, et al

   . The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805–15 doi:10.1016/S1474-4422(07)70216-8 pmid:17706564

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Wingerchuk DM,
   3. Hogancamp WF,
   4. O'Brien PC, et al

   . The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107–14 doi:10.1212/WNL.53.5.1107 pmid:10496275

   Abstract/FREE Full Text
4. 4.↵
   2. Pittock SJ,
   3. Lennon VA,
   4. Krecke K, et al

   . Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390–96 doi:10.1001/archneur.63.3.390 pmid:16533966

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Pittock SJ,
   3. Weinshenker BG,
   4. Lucchinetti CF, et al

   . Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006;63:964–68 doi:10.1001/archneur.63.7.964 pmid:16831965

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Barnett Y,
   3. Sutton IJ,
   4. Ghadiri M, et al

   . Conventional and advanced imaging in neuromyelitis optica. AJNR Am J Neuroradiol 2014;35:1458–66 doi:10.3174/ajnr.A3592 pmid:23764723

   Abstract/FREE Full Text
7. 7.↵
   2. Liang P,
   3. Liu Y,
   4. Jia X, et al

   . Regional homogeneity changes in patients with neuromyelitis optica revealed by resting-state functional MRI. Clin Neurophysiol 2011;122:121–27 doi:10.1016/j.clinph.2010.05.026 pmid:20621555

   CrossRefPubMed
8. 8.↵
   2. Liu Y,
   3. Liang P,
   4. Duan Y, et al

   . Abnormal baseline brain activity in patients with neuromyelitis optica: a resting-state fMRI study. Eur J Radiol 2011;80:407–11 doi:10.1016/j.ejrad.2010.05.002 pmid:20605694

   CrossRefPubMed
9. 9.↵
   2. Yu CS,
   3. Lin FC,
   4. Li KC, et al

   . Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica. AJNR Am J Neuroradiol 2006;27:1009–15 pmid:16687534

   Abstract/FREE Full Text
10. 10.↵
    2. He D,
    3. Wu Q,
    4. Chen X, et al

    . Cognitive impairment and whole brain diffusion in patients with neuromyelitis optica after acute relapse. Brain Cogn 2011;77:80–88 doi:10.1016/j.bandc.2011.05.007 pmid:21723024

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Zhao DD,
    3. Zhou HY,
    4. Wu QZ, et al

    . Diffusion tensor imaging characterization of occult brain damage in relapsing neuromyelitis optica using 3.0T magnetic resonance imaging techniques. Neuroimage 2012;59:3173–77 doi:10.1016/j.neuroimage.2011.11.022 pmid:22108642

    CrossRefPubMed
12. 12.↵
    2. Sánchez-Catasús CA,
    3. Cabrera-Gomez J,
    4. Almaguer Melian W, et al

    . Brain tissue volumes and perfusion change with the number of optic neuritis attacks in relapsing neuromyelitis optica: a voxel-based correlation study. PLoS One 2013;8:e66271 doi:10.1371/journal.pone.0066271 pmid:23824339

    CrossRefPubMed
13. 13.↵
    2. Rocca MA,
    3. Agosta F,
    4. Mezzapesa DM, et al

    . Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology 2004;62:476–78 doi:10.1212/01.WNL.0000106946.08741.41 pmid:14872036

    Abstract/FREE Full Text
14. 14.↵
    2. Chanson JB,
    3. Lamy J,
    4. Rousseau F, et al

    . White matter volume is decreased in the brain of patients with neuromyelitis optica. Eur J Neurol 2013;20:361–67 doi:10.1111/j.1468-1331.2012.03867.x pmid:22978568

    CrossRefPubMed
15. 15.↵
    2. Duan Y,
    3. Liu Y,
    4. Liang P, et al

    . Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study. Eur J Radiol 2012;81:e110–14 doi:10.1016/j.ejrad.2011.01.065 pmid:21316170

    CrossRefPubMed
16. 16.↵
    2. von Glehn F,
    3. Jarius S,
    4. Cavalcanti Lira RP, et al

    . Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders. Mult Scler 2014 Jan 29. [Epub ahead of print] doi:10.1177/1352458513519838 pmid:24477120

    Abstract/FREE Full Text
17. 17.↵
    2. Liu Y,
    3. Xie T,
    4. He Y, et al

    . Cortical thinning correlates with cognitive change in multiple sclerosis but not in neuromyelitis optica. Eur Radiol 2014;24:2334–43 doi:10.1007/s00330-014-3239-1 pmid:24906701

    CrossRefPubMed
18. 18.↵
    2. Blanc F,
    3. Noblet V,
    4. Jung B, et al

    . White matter atrophy and cognitive dysfunctions in neuromyelitis optica. PLoS One 2012;7:e33878 doi:10.1371/journal.pone.0033878 pmid:22509264

    CrossRefPubMed
19. 19.↵
    2. Duan Y,
    3. Liu Y,
    4. Liang P, et al

    . White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study. Acta Radiol 2014;55:589–93 doi:10.1177/0284185113501815 pmid:23966367

    Abstract/FREE Full Text
20. 20.↵
    2. Calabrese M,
    3. Oh MS,
    4. Favaretto A, et al

    . No MRI evidence of cortical lesions in neuromyelitis optica. Neurology 2012;79:1671–76 doi:10.1212/WNL.0b013e31826e9a96 pmid:22993282

    Abstract/FREE Full Text
21. 21.↵
    2. Blanc F,
    3. Zéphir H,
    4. Lebrun C, et al

    . Cognitive functions in neuromyelitis optica. Arch Neurol 2008;65:84–88 pmid:18195143 doi:10.1001/archneurol.2007.16

    CrossRefPubMedWeb of Science
22. 22.↵
    2. He D,
    3. Chen X,
    4. Zhao D, et al

    . Cognitive function, depression, fatigue, and activities of daily living in patients with neuromyelitis optica after acute relapse. Int J Neurosci 2011;121:677–83 doi:10.3109/00207454.2011.608456 pmid:21797812

    CrossRefPubMed
23. 23.↵
    2. Vanotti S,
    3. Cores EV,
    4. Eizaguirre B, et al

    . Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis. Arq Neuropsiquiatr 2013;71:357–61 doi:10.1590/0004-282X20130038 pmid:23828523

    CrossRefPubMed
24. 24.↵
    2. Saji E,
    3. Arakawa M,
    4. Yanagawa K, et al

    . Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann Neurol 2013;73:65–76 doi:10.1002/ana.23721 pmid:23378324

    CrossRefPubMed
25. 25.↵
    2. Yang CS,
    3. Zhang DQ,
    4. Wang JH, et al

    . Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China. CNS Neurosci Ther 2014;20:32–39 doi:10.1111/cns.12156 pmid:23890015

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Blanco-Rojas L,
    3. Arboix A,
    4. Canovas D, et al

    . Cognitive profile in patients with a first-ever lacunar infarct with and without silent lacunes: a comparative study. BMC Neurol 2013;13:203 doi:10.1186/1471-2377-13-203 pmid:24341857

    CrossRefPubMed
27. 27.↵
    2. Barkhof F,
    3. Filippi M,
    4. Miller DH, et al

    . Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120(pt 11):2059–69 doi:10.1093/brain/120.11.2059 pmid:9397021

    Abstract/FREE Full Text
28. 28.↵
    2. Ashburner J

    . A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95–113 doi:10.1016/j.neuroimage.2007.07.007 pmid:17761438

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Papadopoulos MC,
    3. Verkman AS

    . Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012;11:535–44 doi:10.1016/S1474-4422(12)70133-3 pmid:22608667

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Wingerchuk DM,
    3. Weinshenker BG

    . The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler 2012;18:5–10 doi:10.1177/1352458511431077 pmid:22146604

    Abstract/FREE Full Text
31. 31.↵
    2. Freitas E,
    3. Guimarães J

    . Neuromyelitis optica spectrum disorders associated with other autoimmune diseases. Rheumatol Int 2015;35:243–53 doi:10.1007/s00296-014-3066-3 pmid:24952418

    CrossRefPubMed
32. 32.↵
    2. Popescu BF,
    3. Parisi JE,
    4. Cabrera-Gómez JA, et al

    . Absence of cortical demyelination in neuromyelitis optica. Neurology 2010;75:2103–09 doi:10.1212/WNL.0b013e318200d80c pmid:21135384

    Abstract/FREE Full Text
33. 33.↵
    2. Llufriu S,
    3. Martinez-Heras E,
    4. Fortea J, et al

    . Cognitive functions in multiple sclerosis: impact of gray matter integrity. Mult Scler 2014;20:424–32. doi:10.1177/1352458513503722 pmid:24005025

    Abstract/FREE Full Text
34. 34.↵
    2. Tona F,
    3. Petsas N,
    4. Sbardella E, et al

    . Multiple sclerosis: altered thalamic resting-state functional connectivity and its effect on cognitive function. Radiology 2014;271:814–21 doi:10.1148/radiol.14131688 pmid:24484065

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Calabrese M,
    3. Agosta F,
    4. Rinaldi F, et al

    . Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009;66:1144–50 doi:10.1001/archneurol.2009.174 pmid:19752305

    CrossRefPubMedWeb of Science
36. 36.↵
    2. Štecková T,
    3. Hluštík P,
    4. Sládková V, et al

    . Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis. J Neurol Sci 2014;342:62–68 doi:10.1016/j.jns.2014.04.026 pmid:24819917

    CrossRefPubMed
37. 37.↵
    2. Morgen K,
    3. Sammer G,
    4. Courtney SM, et al

    . Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. Neuroimage 2006;30:891–98 doi:10.1016/j.neuroimage.2005.10.032 pmid:16360321

    CrossRefPubMedWeb of Science
38. 38.↵
    2. De Stefano N,
    3. Matthews PM,
    4. Filippi M, et al

    . Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003;60:1157–62 doi:10.1212/01.WNL.0000055926.69643.03 pmid:12682324

    Abstract/FREE Full Text
39. 39.↵
    2. Mesaros S,
    3. Rovaris M,
    4. Pagani E, et al

    . A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Arch Neurol 2008;65:1223–30 doi:10.1001/archneur.65.9.1223 pmid:18779427

    CrossRefPubMedWeb of Science